Characterization of T-cell immune responses in clinical trials of the candidate RTS,S malaria vaccine

por Moris, Philippe, Jongert, Erik, van der Most, Robbert G.
Publicado 2017

Safety and immunogenicity of an investigational 4-component Staphylococcus aureus vaccine with or without AS03(B) adjuvant: Results of a randomized phase I trial

por Levy, Jack, Licini, Laurent, Haelterman, Edwige, Moris, Philippe, Lestrate, Pascal, Damaso, Silvia, Van Belle, Pascale, Boutriau, Dominique
Publicado 2015

An assessment of prime‐boost vaccination schedules with AS03(A)‐adjuvanted prepandemic H5N1 vaccines: a randomized study in European adults

por Gillard, Paul, Caplanusi, Adrian, Knuf, Markus, Roman, François, Walravens, Karl, Moris, Philippe, Dramé, Mamadou, Schwarz, Tino F.
Publicado 2012

A Statistical Interaction between Circumsporozoite Protein-Specific T Cell and Antibody Responses and Risk of Clinical Malaria Episodes following Vaccination with RTS,S/AS01E

por Ndungu, Francis M., Mwacharo, Jedidah, Kimani, Domtila, Kai, Oscar, Moris, Philippe, Jongert, Erik, Vekemans, Johan, Olotu, Ally, Bejon, Philip
Publicado 2012

H5N1 Influenza Vaccine Formulated with AS03(A) Induces Strong Cross-Reactive and Polyfunctional CD4 T-Cell Responses

por Moris, Philippe, van der Most, Robbert, Leroux-Roels, Isabel, Clement, Frédéric, Dramé, Mamadou, Hanon, Emmanuel, Leroux-Roels, Geert G., Van Mechelen, Marcelle
Publicado 2010

A Randomized, Controlled Safety, and Immunogenicity Trial of the M72/AS01 Candidate Tuberculosis Vaccine in HIV-Positive Indian Adults

por Kumarasamy, Nagalingeswaran, Poongulali, Selvamuthu, Bollaerts, Anne, Moris, Philippe, Beulah, Faith Esther, Ayuk, Leo Njock, Demoitié, Marie-Ange, Jongert, Erik, Ofori-Anyinam, Opokua
Publicado 2016

Comparative humoral and cellular immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine in healthy women aged 18–45 years:...

por Einstein, Mark H, Levin, Myron J, Chatterjee, Archana, Chakhtoura, Nahida, Takacs, Peter, Catteau, Grégory, Dessy, Francis J, Moris, Philippe, Lin, Lan, Struyf, Frank, Dubin, Gary
Publicado 2014

Safety and immunogenicity of candidate vaccine M72/AS01(E) in adolescents in a TB endemic setting

por Penn-Nicholson, Adam, Geldenhuys, Hennie, Burny, Wivine, van der Most, Robbert, Day, Cheryl L., Jongert, Erik, Moris, Philippe, Hatherill, Mark, Ofori-Anyinam, Opokua, Hanekom, Willem
Publicado 2015

Protective Immunity Induced with the RTS,S/AS Vaccine Is Associated with IL-2 and TNF-α Producing Effector and Central Memory CD4(+) T Cells

por Lumsden, Joanne M., Schwenk, Robert J., Rein, Lisa E., Moris, Philippe, Janssens, Michel, Ofori-Anyinam, Opokua, Cohen, Joe, Kester, Kent E., Heppner, D. Gray, Krzych, Urszula
Publicado 2011

Superior antigen-specific CD4(+)T-cell response with AS03-adjuvantation of a trivalent influenza vaccine in a randomised trial of adults aged 65 and older

por Couch, Robert B, Bayas, José M, Caso, Covadonga, Mbawuike, Innocent Nnadi, López, Concepción Núñez, Claeys, Carine, El Idrissi, Mohamed, Hervé, Caroline, Laupèze, Béatrice, Oostvogels, Lidia, Moris, Philippe
Publicado 2014

Circumsporozoite-Specific T Cell Responses in Children Vaccinated with RTS,S/AS01(E) and Protection against P falciparum Clinical Malaria

por Olotu, Ally, Moris, Philippe, Mwacharo, Jedidah, Vekemans, Johan, Kimani, Domtila, Janssens, Michel, Kai, Oscar, Jongert, Erik, Lievens, Marc, Leach, Amanda, Villafana, Tonya, Savarese, Barbara, Marsh, Kevin, Cohen, Joe, Bejon, Philip
Publicado 2011

Safety and persistence of the humoral and cellular immune responses induced by 2 doses of an AS03-adjuvanted A(H1N1)pdm09 pandemic influenza vaccine administered to infants, childr...

por Garcia-Sicilia, José, Arístegui, Javier, Omeñaca, Félix, Carmona, Alfonso, Tejedor, Juan C, Merino, José M, García-Corbeira, Pilar, Walravens, Karl, Bambure, Vinod, Moris, Philippe, Caplanusi, Adrian, Gillard, Paul, Dieussaert, Ilse
Publicado 2015

Characterization of B-cell and T-cell responses to a tetravalent dengue purified inactivated vaccine in healthy adults

por Friberg, Heather, Gargulak, Morgan, Kong, Amanda, Lin, Leyi, Martinez, Luis J., Schmidt, Alexander C., Paris, Robert M., Jarman, Richard G., Diaz, Clemente, Thomas, Stephen J., Moris, Philippe, Currier, Jeffrey R.
Publicado 2022

Phase II, randomized, open, controlled study of AS03-adjuvanted H5N1 pre-pandemic influenza vaccine in children aged 3 to 9 years: follow-up of safety and immunogenicity persistenc...

por Díez-Domingo, Javier, Baldó, José-María, Planelles-Catarino, Maria Victoria, Garcés-Sánchez, María, Ubeda, Isabel, Jubert–Rosich, Angels, Marès, Josep, Garcia-Corbeira, Pilar, Moris, Philippe, Teko, Maurice, Vanden Abeele, Carline, Gillard, Paul
Publicado 2015

Randomized, Double-Blind, Reference-Controlled, Phase 2a Study Evaluating the Immunogenicity and Safety of OVX836, A Nucleoprotein-Based Influenza Vaccine

por Leroux-Roels, Isabel, Waerlop, Gwenn, Tourneur, Jessika, De Boever, Fien, Maes, Catherine, Bruhwyler, Jacques, Guyon-Gellin, Delphine, Moris, Philippe, Del Campo, Judith, Willems, Paul, Leroux-Roels, Geert, Le Vert, Alexandre, Nicolas, Florence
Publicado 2022

A Randomized, Controlled Dose-Finding Phase II Study of the M72/AS01 Candidate Tuberculosis Vaccine in Healthy PPD-Positive Adults

por Montoya, Jaime, Solon, Juan Antonio, Cunanan, Soledad Rosanna C., Acosta, Luz, Bollaerts, Anne, Moris, Philippe, Janssens, Michel, Jongert, Erik, Demoitié, Marie-Ange, Mettens, Pascal, Gatchalian, Salvacion, Vinals, Carlota, Cohen, Joe, Ofori-Anyinam, Opokua
Publicado 2013

Cell-mediated immune responses to different formulations of a live-attenuated tetravalent dengue vaccine candidate in subjects living in dengue endemic and non-endemic regions

por Moris, Philippe, Bauer, Kristen M., Currier, Jeffrey R., Friberg, Heather, Eckels, Kenneth H., Esquilin, Ines O., Gibbons, Robert V., Innis, Bruce L., Jarman, Richard G., Simasathien, Sriluck, Sun, Peifang, Thomas, Stephen J., Watanaveeradej, Veerachai
Publicado 2019

First-in-Human Randomized Study to Assess the Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus (RSV) Vaccine Based on Chimpanzee-Adenovirus-155 Viral Vec...

por Cicconi, Paola, Jones, Claire, Sarkar, Esha, Silva-Reyes, Laura, Klenerman, Paul, de Lara, Catherine, Hutchings, Claire, Moris, Philippe, Janssens, Michel, Fissette, Laurence A, Picciolato, Marta, Leach, Amanda, Gonzalez-Lopez, Antonio, Dieussaert, Ilse, Snape, Matthew D
Publicado 2020

Long-Term Safety and Immunogenicity of a Tetravalent Live-Attenuated Dengue Vaccine and Evaluation of a Booster Dose Administered to Healthy Thai Children

por Watanaveeradej, Veerachai, Simasathien, Sriluck, Mammen, Mammen P., Nisalak, Ananda, Tournay, Elodie, Kerdpanich, Phirangkul, Samakoses, Rudiwilai, Putnak, Robert J., Gibbons, Robert V., Yoon, In-Kyu, Jarman, Richard G., De La Barrera, Rafael, Moris, Philippe, Eckels, Kenneth H., Thomas, Stephen J., Innis, Bruce L.
Publicado 2016

Long-term Cross-reactivity Against Nonvaccine Human Papillomavirus Types 31 and 45 After 2- or 3-Dose Schedules of the AS04-Adjuvanted Human HPV-16/18 Vaccine

por Folschweiller, Nicolas, Behre, Ulrich, Dionne, Marc, Durando, Paolo, Esposito, Susanna, Ferguson, Linda, Ferguson, Murdo, Hillemanns, Peter, McNeil, Shelly A, Peters, Klaus, Ramjattan, Brian, Schwarz, Tino F, Supparatpinyo, Khuanchai, Suryakirian, Pemmaraju V, Janssens, Michel, Moris, Philippe, Decreux, Annabelle, Poncelet, Sylviane, Struyf, Frank
Publicado 2019